Lecap Asset Management LTD Apellis Pharmaceuticals, Inc. Transaction History
Lecap Asset Management LTD
- $428 Billion
- Q1 2025
A detailed history of Lecap Asset Management LTD transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Lecap Asset Management LTD holds 10,759 shares of APLS stock, worth $188,712. This represents 0.05% of its overall portfolio holdings.
Number of Shares
10,759Holding current value
$188,712% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
300Shares Held
111MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$214 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$209 Million17.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$176 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$169 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$102 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $1.93B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...